Tiny trial tests artificial vein valve for leg swelling
NCT ID NCT05883943
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new device called the Cook® Venous Valve System in just 4 people with chronic venous insufficiency (leg veins that don't pump blood back to the heart properly). The valve is implanted through a small tube into a deep leg vein to help blood flow one way. The main goal is to check safety in the first 30 days, with follow-ups up to a year.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Cook® Venous Valve System (a permanent prosthetic valve implanted in the leg vein)
- What this could lead to
- If it works, this could offer a new treatment option for chronic venous insufficiency, potentially reducing leg swelling and pain.
- What could go wrong
- This is a very early, tiny study with only 4 people. The device may not work as hoped, and risks include blood clots, bleeding, or device movement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
4 people
The number who actually took part.
- Started
-
Apr 2023
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Limited inclusion criteria: * Documented symptomatic deep venous reflux in one limb * Deep venous reflux in the region of interest Limited exclusion criteria: General: * Age \< 18 years * BMI ≥ 40 * Cultural objections to porcine materials * Unwillingness or inability to comply with the follow-up * Unwillingness to provide study data for duration of study * Simultaneous participation in another device or drug study * Inability or refusal to give informed consent Medical: * Pregnant, or planning to become pregnant * Diagnosis of terminal illness with life expectancy less than 12 months * Complete symptom resolution with compliant compression therapy for three months * Untreated superficial venous disease * Medical interventions including any of the following: planned procedure of any leg, vascular intervention or major surgery within the last three months, implanted inferior vena cava filter * Medical history of any of the following: anticoagulation treatment for pulmonary embolism (within the last six months or ongoing), insulin dependent diabetes, chronic obstructive pulmonary disease, renal dysfunction requiring dialysis, leg amputation, bleeding diathesis, untreated or unresolved systemic infection or local infection, active malignancy except non-melanoma skin cancer, other acute or chronic medical condition that may cause noncompliance with the protocol or confound the study results, documented history of significant untreated stenosis within the arterial system * Positive coronavirus (COVID-19) test six days prior to implant procedure Anatomical: * Inability to clearly visualize target implantation site * Tortuous target implantation site * Inadequate inflow and/or outflow to the target region Procedural: * Inability to gain access to the access site vein * Untreated focal or diffuse stenosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic venous insufficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Angiosur S.A.S.
Antioquia, Colombia
-
Clínica de La Costa S.A.S.
Barranquilla, Colombia
-
Fundacion Oftalmologica De Santander
Santander, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Lab-Grown vein with a Built-In valve fix damaged leg veins?
- Could leg vein disease weaken breathing and strength?
- Blood thinners after vein laser: which works best to stop dangerous clots?
- Mapping pain during vein surgery to make it less uncomfortable
- Could a daily pill ease leg pain and swelling from vein disease?
- Scientists track varicose veins from start to worse